King Chulalongkorn Memorial Hospital

Bangkok, Patumwan 10330

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Risk, Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Extrahepatic, Cholangiocarcinoma, Intrahepatic, Chronic Kidney Disease, Gallbladder Adenocarcinoma, Inflammation

Studies at this site

• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma — Stopped early